ALAINA IANNAZZI: Open Payments
NPI 1912242496 · DOVER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 99 payments from 19 companies in 2025. Trend: 2023 $600 · 2024 $437 · 2025 $2,098
Food & beverage: $2,002Education: $96
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $302 |
| ABBVIE INC. | 17 | $264 |
| Amgen Inc. | 8 | $254 |
| Galderma Laboratories, L.P. | 19 | $224 |
| GENZYME CORPORATION | 7 | $160 |
| Janssen Biotech, Inc. | 11 | $150 |
| Regeneron Healthcare Solutions, Inc. | 3 | $142 |
| Incyte Corporation | 6 | $129 |
| PFIZER INC. | 3 | $105 |
| Organon LLC | 5 | $90 |
Products named: Bimzelx, DUPIXENT, OTEZLA, SKYRIZI, NEMLUVIO, TREMFYA, OPZELURA, CIBINQO.
Industry payments across NH — which companies pay providers there.
